Featured News
![](/sites/default/files/styles/4_3_medium/public/2024/07/02/Doctor-going-through-a-report-with-senior-patient-155317574_6048x4032.jpeg?itok=mlAJ-1MZ)
Press Release
Alzheimer’s Association Statement on European Medicines Agency Negative Opinion on Leqembi for the Treatment of Alzheimer’s Disease
CHICAGO, July 26, 2024 — The Alzheimer’s Association is disappointed by today’s decision by the European Medicines Agency (EMA) to recommend against allowing Leqembi® to be marketed across the Eu...
All News
AIM Blog
Your Vote Matters in the Fight to End Alzheimer's
In 1845 Congress passed a federal law designating the first Tuesday, following the first Monday in November, as Election Day...
AIM Blog
Honoring an Alzheimer's Champion
As those living with Alzheimer's disease know, the disease is devastating not just on the individual but also on their...
AIM Blog
My Tuesday with Tim and Mike
Tuesday morning I received an urgent text. I had a ticket to the Vice Presidential debate and I had only...
AIM Blog
AIM Needs Your Voice in the Next Presidential Debate
Alzheimer's disease continues to be a rising issue in the 2016 election thanks to the tireless work of advocates across...
AIM Blog
The Research Speaks, but Will Congress Listen in its Fight Against Alzheimer's Disease
This content was co-authored by Maria C. Carrillo, PhD, Chief Science Officer of the Alzheimer's Association, and Robert Egge, Chief...
AIM Blog
Tireless Work of Advocates and Champions in Congress Working - Support for HOPE Continues to Grow
We have witnessed the bipartisan leadership in Congress to increase funding for Alzheimer's disease and related dementia research. We are...